ATF3 downmodulates its new targets IFI6 and IFI27 to suppress the growth and migration of tongue squamous cell carcinoma cells
Cited by 36
Related Papers
Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
|The Lancet Respiratory Medicine|2021|183
Genetic Risk for Overall Cancer and the Benefit of Adherence to a Healthy Lifestyle
|Cancer Research|2021|121
A novel lncRNA, LUADT1, promotes lung adenocarcinoma proliferation via the epigenetic suppression of p27
|Cell Death and Disease|2015|112
A cancer-testis non-coding RNA LIN28B-AS1 activates driver gene LIN28B by interacting with IGF2BP1 in lung adenocarcinoma
|Oncogene|2018|88
KIF18B promotes tumor progression through activating the Wnt/β-catenin pathway in cervical cancer
|OncoTargets and Therapy|2018|73